Invivyd, Inc. (IVVD)
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.
$145.72M
Mr. David Hering M.B.A.
101.00
Waltham, MA
-
-0.68
$-1.80
4.03
4.71
-3,854.71%
-0.65
0.00
0.94
25.07
4.57
-114.94%
-109.72%
Similar stocks (15)
Edgewise Therapeutics, Inc.
EWTX
Recursion Pharmaceuticals, Inc.
RXRX
Erasca, Inc.
ERAS
REGENXBIO Inc.
RGNX
C4 Therapeutics, Inc.
CCCC
Atea Pharmaceuticals, Inc.
AVIR
Black Diamond Therapeutics, Inc.
BDTX
Abeona Therapeutics Inc.
ABEO
Generation Bio Co.
GBIO
Kronos Bio, Inc.
KRON
Anebulo Pharmaceuticals, Inc.
ANEB
Passage Bio, Inc.
PASG
Unity Biotechnology, Inc.
UBX
Aptevo Therapeutics Inc.
APVO
TRACON Pharmaceuticals, Inc.
TCON
ETF Exposure (7)
ETFMG Treatments, Testing and Advancements ETF
GERM
0.29%
Schwab U.S. Small-Cap ETF
SCHA
0.0019061449%
ProShares Ultra Russell2000
UWM
0.0010000221944945244%
ProShares UltraPro Russell2000
URTY
4.930097216072378e-4%
ProShares Hedge Replication ETF
HDG
4.1877490245819147e-4%
Schwab U.S. Broad Market ETF
SCHB
1.319707e-4%
Dimensional US Core Equity Market ETF
DFAU
7.659999999999999e-5%
Similar stocks (15)
Edgewise Therapeutics, Inc.
EWTX
Recursion Pharmaceuticals, Inc.
RXRX
Erasca, Inc.
ERAS
REGENXBIO Inc.
RGNX
C4 Therapeutics, Inc.
CCCC
Atea Pharmaceuticals, Inc.
AVIR
Black Diamond Therapeutics, Inc.
BDTX
Abeona Therapeutics Inc.
ABEO
Generation Bio Co.
GBIO
Kronos Bio, Inc.
KRON
Anebulo Pharmaceuticals, Inc.
ANEB
Passage Bio, Inc.
PASG
Unity Biotechnology, Inc.
UBX
Aptevo Therapeutics Inc.
APVO
TRACON Pharmaceuticals, Inc.
TCON
ETF Exposure (7)
ETFMG Treatments, Testing and Advancements ETF
GERM
0.29%
Schwab U.S. Small-Cap ETF
SCHA
0.0019061449%
ProShares Ultra Russell2000
UWM
0.0010000221944945244%
ProShares UltraPro Russell2000
URTY
4.930097216072378e-4%
ProShares Hedge Replication ETF
HDG
4.1877490245819147e-4%
Schwab U.S. Broad Market ETF
SCHB
1.319707e-4%
Dimensional US Core Equity Market ETF
DFAU
7.659999999999999e-5%